The PE Ratio as of November 2024 (TTM) for Taro Pharmaceutical Industries Ltd. (TARO) is 30.05

According to Taro Pharmaceutical Industries Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 30.05. This represents a change of -2.05% compared to the average of 30.68 of the last 4 quarters.

Taro Pharmaceutical Industries Ltd. (TARO) Historical PE Ratio (quarterly & annually)

How has TARO PE Ratio performed in the past?

The mean historical PE Ratio of Taro Pharmaceutical Industries Ltd. over the last ten years is 16.40. The current 30.05 PE Ratio has changed 18.23% with respect to the historical average. Over the past ten years (40 quarters), TARO's PE Ratio was at its highest in in the December 2017 quarter at 57.81. The PE Ratio was at its lowest in in the September 2022 quarter at -100.14.

Taro Pharmaceutical Industries Ltd. (TARO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Taro Pharmaceutical Industries Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Taro Pharmaceutical Industries Ltd. (TARO) Average PE Ratio

How has TARO PE Ratio performed in the past?

The current PE Ratio of Taro Pharmaceutical Industries Ltd. (TARO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Taro Pharmaceutical Industries Ltd. (TARO) PE Ratio vs. Peers

How is TARO’s PE Ratio compared to its peers?

Taro Pharmaceutical Industries Ltd.’s PE Ratio is greater than Eagle Pharmaceuticals, Inc. (0.34), greater than ANI Pharmaceuticals, Inc. (-155.73), less than Phibro Animal Health Corporation (55.24), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than Prestige Consumer Healthcare Inc. (20.46), greater than Amphastar Pharmaceuticals, Inc. (14.01), greater than Pacira BioSciences, Inc. (-8.92), greater than Collegium Pharmaceutical, Inc. (10.91), greater than Organogenesis Holdings Inc. (-72.75), less than Lifecore Biomedical, Inc. (34.50), greater than RedHill Biopharma Ltd. (1.84), greater than Evotec SE (-4.46), less than Supernus Pharmaceuticals, Inc. (33.45), greater than Dr. Reddy's Laboratories Limited (3.74), less than PetIQ, Inc. (69.35),

Build a custom stock screener for Taro Pharmaceutical Industries Ltd. (TARO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taro Pharmaceutical Industries Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taro Pharmaceutical Industries Ltd. (TARO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taro Pharmaceutical Industries Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.